PATEL DINESH V PH D - 26 Feb 2024 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
President and CEO, Director
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D.
Issuer symbol
PTGX
Transactions as of
26 Feb 2024
Transactions value $
-$322,320
Form type
4
Filing time
28 Feb 2024, 20:02:29 UTC
Previous filing
20 Feb 2024
Next filing
01 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Tax liability -$322K -10.9K -1.77% $29.53 605K 26 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 25,000 restricted stock units on February 26, 2024.